1 / 20

Glycomics Profile Analysis by MALDI TOF/MS in Human CSF

Glycomics Profile Analysis by MALDI TOF/MS in Human CSF. Xueli Li, Ph.D., Children’s Hospital of Philadelphia. Introduction. Genetic defects in human glycome 2-3% of the human genome encodes proteins for glycosylation 50% of proteins are glycosylated in human

deleo
Download Presentation

Glycomics Profile Analysis by MALDI TOF/MS in Human CSF

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Glycomics Profile Analysis by MALDI TOF/MS in Human CSF Xueli Li, Ph.D., Children’s Hospital of Philadelphia

  2. Introduction Genetic defects in human glycome 2-3% of the human genome encodes proteins for glycosylation 50% of proteins are glycosylated in human 10 distinct glycoprotein biosynthesis pathways >100 disease causing genes discovered Many still remain unknown

  3. Why CSF glycome? • Glycoproteome and glycome in plasma are limited • Unique glycosylation type and glycogene expression pattern in brain • CSF glycome in human has not been well studied • Does CSF glycome provide us more diagnostic value for CDG ?

  4. Project • CSF free glycome • CSF N-glycome • CSF O-glycome • Study cohort • 166 CSF from patients with undiagnosed neurological disease (NIH/UDP) • 10 CSF normal controls

  5. Methods 400 μl CSF Filter Glycoprotein Free glycan O-Glycan N-Glycan Reduced β-elimination PNGase F Desalted & purified by acetic acid – methanol & resin Desalted & Purified by C18 column Permethylation Permethylation MALDI-TOF MALDI-TOF

  6. “Undiagnosed” Cases • Brother (MM, 11 year old) • Encephalopathy/CP/Spastic Paraparesis • Congenital Hypotonia • Global Developmental Delay • Bilateral Hearing Loss • Multiple Fractures • Recurrent Pneumonias • Low immunoglobulin level, low IgA • Generalized Aminoaciduria • CDG normal by CDT • Sister (IM, 6 year old) • Profound Global Developmental Delay • Congenital Hypotonia • Neonatal Seizures • Cerebral atrophy, small corpus callosum • History of recurrent UTIs • CDG normal by CDT

  7. Sib’s Urine Free Glycan 838.57 885.4 Glu4 or Glu3Man1 Control patient 651.68 1275.35 1241.30 681.57 885.92 1742.86

  8. Differential For Hex4 α1,2 Glucosidase I • Pompe Disease • acid alpha-1,4-glucosidase (GAA), 17q25.2-q25.3 • CDG IIb • glucosidase I (GCS1), 2p13-p12 • Polyglucose Diet X Glc(3)-Man(9)-GlcNAc(2)

  9. Sib’s CSF Free Glycan Control Patient

  10. Abnormal CSF Free Glycans

  11. Freeze Nature Reviews Genetics advance online publication; published online 6 June 2006 | doi:10.1038/nrg1894

  12. Sib’s Plasma N-glycan Glc3Man7

  13. Sib’s CSF N-Glycan Compare with Control Control CSF N-Glycan Patient CSF N-Glycan Wrong slides 3009.22 2805.08

  14. MOGS Seq • Affected male sibling Exon 1 c.65C>A, p.A22E; c.329G>A, p.110R>H; Exon 2 c.370C>T, p.124Q>X • Affected female sibling Exon 1 c.65C>A, p.A22E; c.329G>A, p.110R>H Exon 2 c.370C>T, p.124Q>X • Mother Exon 2 c.370C>T, p.124Q>X • Father Exon 1 c.65C>A, p.A22E; c.329G>A, p.110R>H;

  15. GalNAc Type O-linked Protein Glycosylation Core1 Biosynthesis of Core 1 and Core 2 Core2 Essentials of Glycobiology Second Edition

  16. Plasma O-glycan Profile Monosialyl T antigen 1200 895.584 1000 800 M-core 2 Intens. [a.u.] Disialyl T 600 D-core 2 400 1256.790 I.S. 200 * 1391.894 1705.983 1344.874 0 800 1200 1600 m/z

  17. CSF O-glycan Profiles Control CAD-Def Control and abnormal CSF O-linked glycan

  18. CAD Deficiency

  19. Conclusion • CSF glycome is different and more complex than plasma glycome • Free glycome, N-glycome and O-glycome • CSF glycome may detect CNS-specific defect in protein glycosylation • CSF glycome provides additional information for the diagnosis of CDG

  20. Acknowledgment He Research Lab NIH/UDP Miao He, Ph.D. Mariska Davids, Ph.D. Mohd Raihan Megan Kane, Ph.D. Lynne Wolfe Neal Boerkoel, MD. Ph.D. Bill Gahl, MD. Ph.D.

More Related